<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02100072</url>
  </required_header>
  <id_info>
    <org_study_id>CYN13-MK-HH01</org_study_id>
    <nct_id>NCT02100072</nct_id>
  </id_info>
  <brief_title>Evaluation of 1440nm Laser Assisted Selective Photothermolysis for Treatment of Axillary Hyperhidrosis</brief_title>
  <official_title>Evaluation of 1440nm Laser Assisted Selective Photothermolysis for Treatment of Axillary Hyperhidrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of the Nd:YAG 1440 nm
      wavelength laser for the treatment of primary hyperhidrosis of the axilla.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Starch Iodine test to measure improvement</measure>
    <time_frame>up to 6 months post treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess safety of treatment through collection of events</measure>
    <time_frame>up to 6 months post last treatment</time_frame>
    <description>Patients will be given a 1 week diary to record any side effects they may after treatment and at all visits</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Hyperhidrosis</condition>
  <arm_group>
    <arm_group_label>Nd:YAG 1440 nm laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nd:YAG 1440 nm laser</intervention_name>
    <arm_group_label>Nd:YAG 1440 nm laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A healthy non-smoking male or female between 18-55 years of age

          -  Understand/accept obligation not to receive any other procedures in anatomical areas
             exhibiting axillary hyperhidrosis through 3 months prior to treatment

          -  Understand and accept the obligation and is logistically able to present for all
             scheduled follow-up visits

          -  Clinically diagnosed for primary hyperhidrosis of the axilla.

          -  A self-assessed HDSS score of three (3) or four (4)

        Exclusion Criteria:

          -  Clinical diagnosis of secondary hyperhidrosis

          -  Uncontrolled systemic disease or infection

          -  Concurrent use of any hyperhidrosis treatments other than OTC antiperspirants or
             deodorants

          -  Receipt of Botox® or Dysport® within the past six months

          -  Patients who refuse to stop using OTC antiperspirants 24 hours prior to the day of
             surgery and each of the follow-up visits at 3 months and 6 months that Minors starch
             iodine tests may be performed.

          -  Patients using or having used within 7 days of baseline visit: cholinomimetic agents,
             anticholinergic agents, prescription antiperspirants, any herbal medicine treatments
             or any other treatments for hyperhidrosis except OTC antiperspirant or planning to use
             such agents during the course of the study.

          -  Any previous liposuction/liposculpture or any type of surgery for hyperhidrosis; OR
             any other types of treatments for hyperhidrosis in the area to be treated in the past
             6 months

          -  Has any other medical condition, that, in the investigator's opinion would interfere
             with the subject's participation in the study

          -  Is susceptible to light induced seizures or history of seizures

          -  Has a history of keloid formation

          -  Significant cardiovascular disease

          -  Bleeding disorders

          -  Anti-platelet and anticoagulant medication

          -  Sensitivity to lidocaine or epinephrine

          -  Pregnancy or planned pregnancy

          -  Existing neuromuscular disorders (myasthenia gravis, Eaton-Lambert Syndrome,
             amyotrophic lateral sclerosis)

          -  Electronic implants

          -  Subjects requiring supplemental oxygen

          -  Has therapies or medications which may interfere with the treatment (including
             medications causing photosensitivity

          -  Allergic to Doxycycline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Krantz</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Skin Care Physicians</name>
      <address>
        <city>Chestnut Hill</city>
        <state>Massachusetts</state>
        <zip>02467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2014</study_first_submitted>
  <study_first_submitted_qc>March 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2014</study_first_posted>
  <last_update_submitted>July 29, 2015</last_update_submitted>
  <last_update_submitted_qc>July 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperhidrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

